Sofosbuvir & Ledipasvir Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 90 mg Ledipasvir / 400 mg Sofosbuvir
Reference Brands: Harvoni® (EU & US)
Category: Hepatitis
Sofosbuvir & Ledipasvir Tablets is available in Tablet and strengths such as 90 mg Ledipasvir / 400 mg Sofosbuvir. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sofosbuvir & Ledipasvir Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sofosbuvir & Ledipasvir Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Sofosbuvir & Ledipasvir Tablets are a fixed-dose oral antiviral combination used to treat chronic Hepatitis C virus (HCV) infection. Marketed globally under the brand name Harvoni®, this potent direct-acting antiviral (DAA) therapy combines 90 mg Ledipasvir and 400 mg Sofosbuvir to inhibit viral replication. Approved by the US FDA and EMA, it offers a highly effective, once-daily regimen with excellent safety and tolerability profiles. Essential for pharma B2B suppliers and healthcare providers in the EU and US, Sofosbuvir & Ledipasvir supports global efforts to eliminate Hepatitis C through curative treatment options.
Frequently Asked Questions
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Glecaprevir/Pibrentasvir
Strength:
Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®
View Details
Ribavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
